In particular, further studies are needed to reveal the complex regulatory network between LINC00310, c‐Myc and CDK4, which may assist not only in the understanding of underlying mechanisms of the lncRNA‐mediated tumorigenesis, but also in the identification of novel therapeutic targets for breast cancer. Here, MYC is linked to breast cancer.